Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients

World Journal of Gastroenterology

Volumn 12, Issue 33, 2006, Pages 5336-5343

  Colecchia, A ^a   Mazzella, G ^a   Sandri, L ^a   Azzaroli, F ^a   Magliuolo, M ^a   Simoni, P ^a   Bacchi Reggiani, M L ^a   Roda, E ^a   Festi, Davide ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bile acids; Biliary cholesterol; Deoxycholic acid; Gallbladder emptying; Gastric emptying; Intestinal transit; Tauroursodeoxycholic acid

Indexed keywords

BILE ACID; CHOLESTEROL; PLACEBO; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTEROL BILE LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; ECHOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GALLBLADDER EMPTYING; GALLSTONE; GASTROINTESTINAL MOTILITY DISORDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE TRANSIT TIME; MALE; SINGLE BLIND PROCEDURE; STOMACH EMPTYING; SYMPTOM; TREATMENT OUTCOME;

EID: 33749419145     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i33.5336     Document Type: Article

References (49)

1. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, Okoliksanyi L, Ricci G, Capocaccia R, Festi D. Epidemiology of gallstones disease in Italy: Prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.Col). Am J Epidemiol 1995; 141: 158-165
2. Festi D, Sottili S, Colecchia A, Attili A, Mazzella G, Roda E, Romano F. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 1999; 30: 839-846
3. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-1511
4. Khanuja B, Cheah YC, Hunt M, Nishina PM, Wang DQ, Chen HW, Billheimer JT, Carey MC, Paigen B. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 1995; 92: 7729-7733
5. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis, Eur J Clin Invest 1996; 26: 343-352
6. Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, Parini P, Orsini M, Primerano AM, Mazzella G. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990; 99: 1779-1785
7. Thomas LA, Veysey MJ, Bathgate T, King A, French G, Smeeton NC, Murphy GM, Dowling RH. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology 2000; 119: 806-815
8. Azzaroli F, Mazzella G, Mazzeo C, Simoni P, Festi D, Colecchia A, Montagnani M, Martino C, Villanova N, Roda A, Roda E. Sluggish small bowel motility is involved in determining increased biliary deoxycholic acid in cholesterol gallstone patients. Am J Gastroenterol 1999; 94: 2453-2459
9. Portincasa P, Di Ciaula A, Palmieri V, Velardi A, VanBerge-Henegouwen GP, Palasciano G. Impaired gallbladder and gastric motility and pathological gastro-oesophageal reflux in gallstone patients. Eur J Clin Invest 1997; 27: 653-661
10. Roda E, Aldini R, Bazzoli F, Festi D, Mazzella G, Roda A. Pathophysiology and pharmacotherapy of cholelithiasis. Pharmacol Ther 1992; 53: 167-185
11. Hempfling W, Dilger K, Beuers U. Systematic review: ursodeoxycholic acid - adverse effects and drug interactions. Aliment Pharmacol Ther 2003; 18: 963-972
12. Ponz de Leon M, Carulli N, Loria P, Iori R, Zironi F. Cholesterol absorption during bile acid feeding. Effect of ursodeoxycholic acid (UDCA) administration. Gastroenterology 1980; 78: 214-219
13. Wang DQ, Tazuma S, Cohen DE, Carey MC. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am J Physiol Gastrointest Liver Physiol 2003; 285: G494-502
14. LaRusso NF, Thistle JL. Effect of litholytic bile acids on cholesterol absorption in gallstone patients. Gastroenterology 1983; 84: 265-271
15. Woollett LA, Buckley DD, Yao L, Jones PJ, Granholm NA, Tolley EA, Heubi JE. Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. J Lipid Res 2003; 44: 935-942
16. Su CC, Park JY, Higuchi WI, Alkan MH, Corrigan OI, Hofmann AF, Danzinger RG. Mesophase formation during in vitro cholesterol gallstone dissolution: a specific effect of ursodeoxycholic acid. J Pharm Sci 1981; 70: 713-715
17. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988; 319: 1567-1572
18. Tomida S, Abei M, Yamaguchi T, Matsuzaki Y, Shoda J, Tanaka N, Osuga T. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999; 30: 6-13
19. van Erpecum KJ, van Berge Henegouwen GP, Stolk MF, Hopman WP, Jansen JB, Lamers CB. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects. Gastroenterology 1990; 99: 836-842
20. Colecchia A, Sandri L, Simoni P. Effect of chronic administration of ursodeoxycholic acid on gallbladder and gastrointestinal motility in gallstone patients and healthy controls. Gastroenterology 2004; 126: A234
21. Roda E, Festi D, Lezoche E, Leuschner U, Paumgartnet G, Sauerbruch T. Strategies in the treatment of biliary stones. Gastroenterol Int 2000; 13: 7-15
22. Hofmann AF. The enterohepatic circulation of bile acids in health and diseases. In: Gastrointestinal disease, Pathophysiology, Diagnosis and Management., Sleisenger MH, Fordtran S, Eds, Philadelphia, Saunders, 1993: 127-150
23. Simoni P, Sabatini L, Baraldini M, Mirasoli M, Roda A, Roda E. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration. Int J Clin Pharmacol Res 2002; 22: 37-45
24. Roda A, Gioacchini AM, Cerre C, Baraldini M. High-performance liquid chromatographic-electrospray mass spectrometric analysis of bile acids in biological fluids. J Chromatogr B Biomed Appl 1995; 665: 281-294
25. Portincasa P, Colecchia A, Di Ciaula A, Larocca A, Muraca M, Palasciano G, Roda E, Festi D. Standards for diagnosis of gastrointestinal motility disorders. Section: ultrasonography. A position statement from the Gruppo Italiano di Studio Motilita Apparato Digerente. Dig Liver Dis 2000; 32: 160-172
26. Pauletzki J, Paumgartner G. Review article: defects in gallbladder motor function - role in gallstone formation and recurrence. Aliment Pharmacol Ther 2000; 14 Suppl 2: 32-34
27. Shoda J, He BF, Tanaka N, Matsuzaki Y, Osuga T, Yamamori S, Miyazaki H, Sjovall J. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995; 21: 1291-1302
28. Xu QW, Scott RB, Tan DT, Shaffer EA. Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin. Gut 1998; 43: 817-822
29. Chen Q, Amaral J, Biancani P, Behar J. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology 1999; 116: 678-685
30. Chen Q, Amaral J, Oh S, Biancani P, Behar J. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology 1997; 113: 930-937
31. Kano M, Shoda J, Satoh S, Kobayashi M, Matsuzaki Y, Abei M, Tanaka N. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin. J Lab Clin Med 2002; 139: 285-294
32. Marcus SN, Heaton KW. Deoxycholic acid and the pathogenesis of gall stones. Gut 1988; 29: 522-533
33. Noshiro H, Chijiiwa K, Makino I, Nakano K, Hirota I. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones. Gut 1995; 36: 121-125
34. Gustafsson U, Sahlin S, Einarsson C. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones. Eur J Clin Invest 2000; 30: 1099-1106
35. Xu Q, Shaffer EA. The influence of bile salts on small intestinal motility in the guinea pig in vitro. Gastroenterology 1992; 103: 29-35
36. Jun JY, Choi S, Chang IY, Yoon CK, Jeong HG, Kong ID, So I, Kim KW, You HJ. Deoxycholic acid inhibits pacemaker currents by activating ATP-dependent K+ channels through prostaglandin E2 in interstitial cells of Cajal from the murine small intestine. Br J Pharmacol 2005; 144: 242-251
37. Xu QW, Freedman SM, Shaffer EA. Inhibitory effect of bile salts on gallbladder smooth muscle contractility in the guinea pig in vitro. Gastroenterology 1997; 112: 1699-1706
38. Feldman S, Gibaldi M. Effect of bile salts on gastric emptying and intestinal transit in the rat. Gastroenterology 1968; 54: 918-921
39. Walker JP, Khalil T, Wiener I, Fagan CJ, Townsend CM Jr, Greeley GH Jr, Thompson JC. The role of neurotensin in human gallbladder motility. Ann Surg 1985; 201: 678-683
40. Blackburn AM, Fletcher DR, Bloom SR, Christofides ND, Long RG, Fitzpatrick ML, Baron JH. Effect of neurotensin on gastric function in man. Lancet 1980; 1: 987-989
41. Xu QW, Scott RB, Tan DT, Shaffer EA. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel. Hepatology 1996; 23: 1664-1672
42. Xiao ZL, Chen Q, Amaral J, Biancani P, Jensen RT, Behar J. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol 1999; 276: G1401-1407
43. Bialecki RA, Tulenko TN. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am J Physiol 1989; 257: C306-314
44. Wang DQ, Schmitz F, Kopin AS, Carey MC. Targeted disruption of the murine cholecystokinin-1 receptor promotes intestinal cholesterol absorption and susceptibility to cholesterol cholelithiasis. J Clin Invest 2004; 114: 521-528
45. Xiao ZL, Rho AK, Biancani P, Behar J. Effects of bile acids on the muscle functions of guinea pig gallbladder. Am J Physiol Gastrointest Liver Physiol 2002; 283: G87-94
46. van de Heijning BJ, van de Meeberg PC, Portincasa P, Doornewaard H, Hoebers FJ, van Erpecum KJ, Vanberge-Henegouwen GP. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci 1999; 44: 190-196
47. Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study. Hepatology 1982; 2: 804-810
48. Jazrawi RP. Normal gallbladder motor function. In: Afdhal NH, ed. Gallbladder and Biliary Tract Diseases. New York Marcel Dekker Inc, 2000: 251-274
49. Fischer S, Muller I, Zundt BZ, Jungst C, Meyer G, Jungst D. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones. Eur J Gastroenterol Hepatol 2004; 16: 305-311